Righting the shipSir Andrew WittyCEOGlaxoSmithKline
Since Andrew Witty beat Chris Viehbacher and at least one other candidate for the top job at GlaxoSmithKline ($GSK) in 2007, he has led several efforts to right a ship that had sailed in the wrong dir…
Archive for the ‘Advair’ Category
Sir Andrew Witty – The 25 most influential people in biopharma today
February 7th, 2012 
Ryan McBride 
Posted in Advair, Andrew Witty, Avandia, Blog, Companies, Diagnostics, Funding, GlaxoSmithKline, Impax Labs, Medical Devices, Medical Supply, Pharmaceuticals, Relovair, Startups, Theravance, Universities, Videos 
Tags: biotech food social media 
Comments OffTheravance shares tank on troubling study results for Relovair
January 9th, 2012 Biotech News by Suzanne Elvidge and John Carroll
Shares of GlaxoSmithKline ($GSK) caught a chill this morning after investigators released mixed late-stage data and flagged troubling safety concerns for its COPD and asthma therapy Relovair. Shares of the pharma gia…
Posted in Advair, Blog, Clinical Trial Results, Companies, COPD, Diagnostics, Funding, GlaxoSmithKline, Medical Devices, Medical Supply, Pharmaceuticals, Relovair, Startups, Theravance, Universities, Videos Tags: biotech food social media Comments Off